Sign up for the QMED & MD+DI Daily newsletter.
October 22, 2009
1 Min Read
Sebra (Tucson, AZ) has announced the sale of its Blood Collection and Processing division to Haemonetics Corp. (Braintree, MA). With the sale of this division, Sebra plans to concentrate on strengthening its Medical Technologies division and its offerings to the medical device industry. As part of this objective, Sebra will also focus efforts in the coming months on rebranding the company, which will entail the unveiling of a new name that reflects its role in the medtech marketplace."We are focused on enhancing our existing products and services as well as offering new, innovative technologies and solutions to medical device manufacturing and biopharmaceutical companies throughout the world," according to a statement by the company.Specializing in catheter manufacturing equipment, the company's current product line includes the Saffire and Pirf systems in addition to a range of accessories. Sebra also provides a variety of engineering consulting services.
You May Also Like
Empatica Launch Next-Gen FDA-Cleared Epilepsy WatchMar 1, 2024|2 Min Read
Safeguard Medical Devices: A Complete Approach to Device Lifecycle SecurityApr 4, 2024|13:00 EDT
Boston Sci Nabs FDA Approval for Agent DCBMar 1, 2024|2 Min Read
Masimo Takes Apple's Hail Mary Pass in StrideFeb 29, 2024|3 Min Read